LENZ Therapeutics (LENZ) Long-Term Investments: 2022
Historic Long-Term Investments for Therapeutics (LENZ) over the last 1 years, with Dec 2022 value amounting to $15.3 million.
- Therapeutics' Long-Term Investments was N/A to $15.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $15.3 million, marking a year-over-year change of. This contributed to the annual value of $15.3 million for FY2022, which is N/A change from last year.
- As of Q4 2022, Therapeutics' Long-Term Investments stood at $15.3 million, which was up 14.32% from $13.4 million recorded in Q3 2022.
- In the past 5 years, Therapeutics' Long-Term Investments ranged from a high of $15.3 million in Q4 2022 and a low of $6.0 million during Q2 2022.
- Over the past 1 years, Therapeutics' median Long-Term Investments value was $13.2 million (recorded in 2022), while the average stood at $11.9 million.